McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
| Revenue (TTM) | $403.43B |
| Gross Profit (TTM) | $14.53B |
| EBITDA | $6.88B |
| Operating Margin | 2.21% |
| Return on Equity | 0.00% |
| Return on Assets | 4.99% |
| Revenue/Share (TTM) | $3264.00 |
| Book Value | $-18.10 |
| Price-to-Book | 4.92 |
| Price-to-Sales (TTM) | 0.24 |
| EV/Revenue | 0.239 |
| EV/EBITDA | 13.44 |
| Quarterly Earnings Growth (YoY) | 37.20% |
| Quarterly Revenue Growth (YoY) | 6.00% |
| Shares Outstanding | $117.08M |
| Float | $120.01M |
| % Insiders | 0.05% |
| % Institutions | 95.94% |
Volatility is currently contracting
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson (MCK) closed the most recent trading day at $807.33, moving +2.95% from the previous trading session.
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson (MCK) concluded the recent trading session at $747.53, signifying a -2.09% move from its prior day's close.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
